Product Overview: Atomoxet
Atomoxet 10 mg is a norepinephrine reuptake inhibitor manufactured by Healing Pharma for in-vitro laboratory research purposes. This compound selectively blocks the presynaptic norepinephrine transporter, preventing reuptake and increasing synaptic concentrations of norepinephrine in preclinical models. Researchers at Stroid UK Shop utilise Atomoxet to investigate attention-related neurotransmitter pathways and examine the role of noradrenergic signalling in cognitive function studies.
Laboratory Applications
In laboratory settings, researchers examine Atomoxet’s effects on noradrenergic transmission mechanisms. The compound demonstrates high selectivity for norepinephrine transporters with minimal activity at serotonin or dopamine reuptake sites in cellular assays. Studies investigate its pharmacokinetic properties, receptor binding affinity, and metabolic pathways in controlled research environments. Atomoxet research complements studies involving SARMs for comprehensive neurochemical investigations. Researchers also compare its mechanisms with peptide-based neuromodulators. The compound’s oral bioavailability and long half-life make it suitable for sustained research protocols examining chronic noradrenergic modulation effects in laboratory models.
Technical Specifications
| Parameter | Value |
|---|---|
| Active Ingredient | Atomoxetine Hydrochloride |
| Dosage Form | Oral Tablets |
| Strength | 10 mg per tablet |
| Manufacturer | Healing Pharma |
| CAS Number | Verify with supplier |
| Molecular Formula | Verify with supplier |
| Storage Conditions | Room temperature, dry environment |
| Research Grade | Laboratory standard |
Researchers studying noradrenergic systems can explore additional compounds through our specialised research categories to develop comprehensive experimental protocols.
Research Compliance
Atomoxet 10 mg is supplied exclusively for in-vitro laboratory research purposes and is not intended for human consumption, clinical use, or therapeutic applications. Researchers must ensure compliance with all applicable regulations and institutional guidelines when conducting studies with this compound. Proper laboratory safety protocols, waste disposal procedures, and documentation standards must be maintained throughout all research activities involving this product.
